image
Biodexa Pharmaceuticals Plc BDRX
Healthcare - Biotechnology - NASDAQ - GB
Watchlist
$ 3.62
-25.9 %
$ 2.1 M
Market Cap
-0.05
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -45.49% 7.54% 10.28%
Annual Report FY 10-K 2022-12-31 20.93% -40.22% -27.64%
Annual Report FY 10-K 2021-12-31 68.51% 75.39% 34.42%
Annual Report FY 10-K 2020-12-31 -49.11% -142.82% 5.72%
Annual Report FY 10-K 2019-12-31 -65.22% 11.86% 4.21%
Annual Report FY 10-K 2018-12-31 95.96% 11.42% -0.33%
Annual Report FY 10-K 2017-12-31 -25.25% -89.99% -22.01%
Annual Report FY 10-K 2016-12-31 -3.78% 38.99% 4.36%
Annual Report FY 10-K 2015-12-31 775.80% -14.48% -30.81%
Annual Report FY 10-K 2014-12-31 6.80% -116.01% -71.48%
Annual Report FY 10-K 2013-12-31 0.00% -2.25% -12.25%
Annual Report FY 10-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2024-06-30 0.00% 7.29% 0.49%
Quarterly Report Q1 8-K 2024-03-31 0.00% 7.29% 0.49%
Quarterly Report Q4 8-K 2023-12-31 -64.07% 23.59% 0.63%
Quarterly Report Q3 8-K 2023-09-30 -64.07% 23.59% 37.80%
Quarterly Report Q2 8-K 2023-06-30 -36.32% -16.56% -12.33%
Quarterly Report Q1 8-K 2023-03-31 -36.32% -16.56% -12.33%
Quarterly Report Q4 8-K 2022-12-31 30.51% -99.26% -0.80%
Quarterly Report Q3 8-K 2022-09-30 30.51% -99.26% -0.80%
Quarterly Report Q2 8-K 2022-06-30 16.71% 2.95% -16.82%
Quarterly Report Q1 8-K 2022-03-31 16.71% 2.95% -16.82%
Quarterly Report Q4 8-K 2021-12-31 1.14% 51.65% 40.98%
Quarterly Report Q3 8-K 2021-09-30 1.14% 51.65% -158.34%
Quarterly Report Q2 8-K 2021-06-30 138.69% 81.89% 52.12%
Quarterly Report Q1 8-K 2021-03-31 138.69% 81.89% 52.12%
Quarterly Report Q4 8-K 2020-12-31 -61.28% -7.92% -21.61%
Quarterly Report Q3 8-K 2020-09-30 -61.28% -7.92% 72.22%
Quarterly Report Q2 8-K 2020-06-30 -69.40% -209.96% -7.72%
Quarterly Report Q1 8-K 2020-03-31 -69.40% -209.96% -7.72%
Quarterly Report Q2 8-K 2019-06-30 -12.40% 22.05% -1.96%
Quarterly Report Q1 8-K 2019-03-31 -12.40% 22.05% -1.96%
Quarterly Report Q2 8-K 2018-06-30 16.07% 6.89% 5.47%
Quarterly Report Q1 8-K 2018-03-31 16.07% 6.89% 5.47%
Quarterly Report Q4 8-K 2017-12-31 107.14% -35.33% -50.40%
Quarterly Report Q3 8-K 2017-09-30 -87.01% 52.59% 41.81%
Quarterly Report Q2 8-K 2017-06-30 -83.97% 26.44% 35.82%
Quarterly Report Q1 8-K 2017-03-31 -83.97% 26.44% 35.82%
Quarterly Report Q4 8-K 2016-12-31 -687.73% 408.26% 311.44%
Quarterly Report Q3 8-K 2016-09-30 277.93% -129.72% -83.13%
Quarterly Report Q2 8-K 2016-06-30 810.80% -67.65% -96.26%
Quarterly Report Q1 8-K 2016-03-31 810.80% -67.65% -96.26%
Quarterly Report Q4 8-K 2015-12-31 768.60% 9.70% -14.99%
Quarterly Report Q3 8-K 2015-09-30 768.60% 17.17% 4.64%
Quarterly Report Q2 8-K 2015-06-30 800.00% -74.91% -70.64%
Quarterly Report Q1 8-K 2015-03-31 800.00% -74.91% -70.64%
Quarterly Report Q4 8-K 2014-12-31 -7.63% -189.50% -97.51%
Quarterly Report Q3 8-K 2014-09-30 -7.63% -215.62% -138.16%
Quarterly Report Q2 8-K 2014-06-30 125.00% -33.68% -29.99%
Quarterly Report Q1 8-K 2014-03-31 125.00% -33.68% -29.99%
Quarterly Report Q4 8-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%